Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181) |
---|
01/27/2005 | WO2005006899A1 Treatment of male sexual dysfunction |
01/27/2005 | US20050020635 C7 carbamoyloxy substituted taxane compositions |
01/27/2005 | US20050020500 Glycosaminoglycan-polypeptide complex; antiarthritic agents |
01/27/2005 | CA2533177A1 Treatment of male sexual dysfunction |
01/26/2005 | EP1499589A1 Derivatives of n-phenyl(piperidin-2-yl)methyl benzamide, the preparation method thereof and application of same in therapeutics |
01/26/2005 | CN1571770A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
01/26/2005 | CN1571675A Treatment and diagnosis of insulin-resistant states |
01/26/2005 | CN1571670A Treating sexual desire disorders with flibanserin |
01/26/2005 | CN1571658A Pharmaceutical formulation comprising (R)-bicalutamide |
01/26/2005 | CN1186340C C10 carbonate substituted taxanes as antitumor agents |
01/20/2005 | WO2005004989A2 Film comprising therapeutic agents |
01/20/2005 | WO2005004988A2 Compositions and methods relating to novel compounds and targets thereof |
01/20/2005 | US20050014795 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
01/20/2005 | US20050014788 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
01/20/2005 | US20050014766 Use of n-(indolecarbonyl-)piperazine derivatives |
01/20/2005 | CA2530843A1 Film comprising therapeutic agents |
01/19/2005 | EP1497266A2 Quinoline derivatives and their use as 5-ht6 ligands |
01/19/2005 | EP1272199B1 Combination therapies with vascular damaging activity |
01/19/2005 | CN1568207A 2-amino-6-(2, 4, 5-substituted-phenyl)-pyridines |
01/19/2005 | CN1568183A Citalopram for the treatment of elevated blood pressure |
01/13/2005 | US20050009920 Taxol enhancer compounds |
01/13/2005 | US20050009150 Humanized antibodies that recognize beta amyloid peptide |
01/12/2005 | CN1564683A Methods for treating dry eye by a combination of an antiinflammatory steroid and a MUC-1 secretagogue |
01/12/2005 | CN1184208C Substituted benzimidazoles and their prepn. and use |
01/11/2005 | US6840244 Condom with an erectogenic composition |
01/06/2005 | WO2005000405A2 P38 kinase inhibitor compositions and methods of use |
01/06/2005 | WO2005000404A2 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss |
01/06/2005 | WO2005000403A2 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof |
01/06/2005 | WO2005000402A2 Anti-adhesion composites and methods os use thereof |
01/06/2005 | WO2003042177A8 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
01/06/2005 | US20050004204 2-Iminopyrrolidine derivatives |
01/06/2005 | US20050004197 Thrombin receptors antagonists; oral efficacy |
01/06/2005 | US20050004120 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
01/06/2005 | US20050004099 Spiroazabicyclic heterocyclic compounds |
01/06/2005 | CA2839032A1 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof |
01/06/2005 | CA2535980A1 P38 kinase inhibitor compositions and methods of use |
01/06/2005 | CA2527079A1 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss |
01/06/2005 | CA2526490A1 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof |
01/06/2005 | CA2525788A1 Anti-adhesion composites and methods of use thereof |
01/05/2005 | EP1109537B1 Immediate release oral formulation comprising peptide thrombin inhibitors and a combination of microcrystalline cellulose and sodium starch glycollate |
01/05/2005 | CN1183128C N-(heterocyclic)-benzene or pyridine sulphozmides as antithrombotic agents and anticoagulants |
12/29/2004 | WO2003045392A8 Use of n-(indolcarbonyl-)piperazine derivatives |
12/29/2004 | EP1490361A1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
12/29/2004 | EP1490049A1 Citalopram for the treatment of elevated blood pressure |
12/29/2004 | CN1181886C Application of TNF-derived peptides in the treatment of oedema |
12/23/2004 | US20040258777 Aqueous topical solutions stimulate endothelial growth factors and microcirculation; solvent extraction with volatile non-aqueous solvents; obestity; reduction of cellulite and localized dermal adipose deposits |
12/23/2004 | US20040258739 Plaster for the treatment of dysfunctions and disorders of nails |
12/22/2004 | CN1556805A Piperidine derivative as NMDA receptor antagonist |
12/16/2004 | WO2004108728A1 Cannabinoid receptor ligands and uses thereof |
12/16/2004 | US20040254376 Cyclic amidine derivative |
12/16/2004 | CA2525752A1 Cannabinoid receptor ligands and uses thereof |
12/15/2004 | EP1226137B8 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
12/15/2004 | CN1555259A use of substituted aminomethyl chromans for the treatment of movement disorders and of adverse effects induced by drugs administered to treat extrapyramidal movement disorders |
12/15/2004 | CN1179753C Contraceptive compositions containing antiprogesting and progestinic |
12/14/2004 | US6830765 Extract of green tea containing from 20% to 50% by mass of catechols expressed as epigallocatechol gallate |
12/09/2004 | US20040248936 such as (R)-1-{4-[4-(4-Phenoxy-2-propyl-phenoxy)-butoxy]-benzenesulfonyl}-azetidine-2-carboxylic acid, used as peroxisome proliferator-activated receptor agonists; hypoglycemic agents |
12/09/2004 | US20040248902 Central nervous system, gastrointestinal and psycological disorders; such as 3-(4-chlorobenzenesulfonyl)-2-methyl-7-piperazin-1-yl-1H-indole; synthesis |
12/09/2004 | US20040248881 such as 1-[2-(2-chloro-phenyl)-3-(4-fluoro-phenyl)-2H-pyrazolo[3,4-d]pyridazin-7-yl]-4-isopropylamino-piperidine-4-carboxylic acid amide; for treatment of eating disorders and psychological disorders |
12/09/2004 | US20040248848 Use of specific dose of fondaparinux sodium for the treatment of acs |
12/08/2004 | EP1220856B1 Pyrazolo[4,3-d]pyrimidine derivatives |
12/08/2004 | CN1553895A Taxol enhancer compounds |
12/08/2004 | CN1553894A Taxol enhancer compounds |
12/08/2004 | CN1553801A Inhalation compositions comprising tricyclic 5,6-dihydro-9H-pyrazolo (3,4-C)-1,2,4-triazolo (4,3-alpha) pyridines |
12/08/2004 | CN1178652C Mizoribine tablet with improved colour |
12/02/2004 | WO2004104007A1 Pyrazolo-quinazoline derivatives,process for their preparation and their use as kinase inhibitors |
12/02/2004 | US20040242627 2-Iminoimidazole derivatives (1) |
12/02/2004 | US20040242617 Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
12/02/2004 | US20040242606 Anti-cancer cyclopenta (g)quinazoline compounds |
12/02/2004 | US20040242597 Combination |
12/02/2004 | US20040242578 Pyrimidineamines as angiogenesis modulators |
12/02/2004 | US20040242536 controlled-release mixtures of plant extracts, gelation polymers and drugs such as ximelagatran, used for prophylaxis of cardiovascular disorders |
12/01/2004 | EP1481992A2 Humanized antibodies that sequester amyloid beta peptide |
12/01/2004 | EP1480975A2 Chemical compounds |
12/01/2004 | EP1480948A1 Semicarbazide derivatives and their use as antithrombotics |
12/01/2004 | EP1257584B9 Humanized antibodies that sequester amyloid beta peptide |
12/01/2004 | CN1551885A Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments |
12/01/2004 | CN1551872A Biologically active methylene blue derivatives |
12/01/2004 | CN1551767A Cancer treatment |
11/25/2004 | WO2004101071A2 Infusion hub assembly and inserter |
11/25/2004 | US20040235920 Novel use of substituted aminomethyl chromans for the treatment of movement disorders and of adverse effects induced by drugs administered to treat extrapyramidal movement disorders |
11/25/2004 | US20040235909 substituted bis/thiohydrazide amide compound; synergistic effect with taxol or taxotere, anticancer agents, side effect reduction |
11/25/2004 | US20040235894 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of asthma and/or rhinitis; respiratory system disorders |
11/24/2004 | EP1478366A1 Pharmaceutical combinations of cox-2 inhibitors and opiates |
11/24/2004 | CN1549813A Pyrimidineamines as angiogenesis modulators |
11/24/2004 | CN1549812A Pyrazole compounds useful as protein kinase inhibitors. |
11/18/2004 | US20040229923 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying |
11/18/2004 | US20040229790 Substance having an activity which modulates or inhibits proliferation of AILIM(activation inducible lymphocyte immunomodulatory molecule)-expressing cells or production of a cytokine; for treatment of rheumatoid arthritis, osteoarthritis |
11/18/2004 | DE10297331T5 Behandlung und Diagnose von Insulin-resistenten Zuständen Treatment and diagnosis of insulin-resistant conditions |
11/17/2004 | EP1476471A1 Nutraceuticals for the treatment, protection and restoration of connective tissues |
11/17/2004 | EP1476162A1 Controlled synthesis of ziprasidone and compositions thereof |
11/17/2004 | EP1272468B1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
11/17/2004 | EP1185274B1 Drug combinations comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4 |
11/17/2004 | CN1547474A Skin-permeable selective cyclooxygenase-2 inhibitor composition |
11/16/2004 | US6818672 Treating endometriosis or infertility, or improving fertility |
11/11/2004 | US20040225139 a 3-oxo-androstrane carbothioic acid compound |
11/11/2004 | US20040224961 Novel thiazolo (4,5-D) pyrimidine compounds |
11/11/2004 | US20040224934 3 -oxo-androstrane carbothioic acid compound |
11/11/2004 | US20040224931 3-oxo-androstrane carbothioic acid compound |
11/10/2004 | EP1474395A1 Nicotinamide derivates useful as p38 inhibitors |
11/10/2004 | EP1474117A1 Composition for inhalation |